SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Laboratory Corp of America Holdings – ‘8-K’ for 11/28/01

On:  Wednesday, 11/28/01   ·   For:  11/28/01   ·   Accession #:  920148-1-500042   ·   File #:  1-11353

Previous ‘8-K’:  ‘8-K’ on / for 11/14/01   ·   Next:  ‘8-K’ on / for 12/4/01   ·   Latest:  ‘8-K’ on / for 10/27/20

Magnifying glass tilted right emoji
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size

11/28/01  Lab Corp of America Holdings      8-K:9      11/28/01    1:4K

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Company 8-K                                            2±    11K 

Document Table of Contents

Page (sequential) | (alphabetic) Top
11st Page   -   Filing Submission
"Item 9. Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 28, 2001 ------------------ (Date of earliest event reported) LABORATORY CORPORATION OF AMERICA HOLDINGS ------------------------------------------ (Exact name of registrant as specified in its charter) DELAWARE 1-11353 13-3757370 -------------- ----------- -------------- (State or other (Commission (IRS Employer jurisdiction of File Number) Identification incorporation) Number) 358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215 ------------------------------------------------------- (Address of principal executive offices) 336-229-1127 ------------ (Registrant's telephone number, including area code) ITEM 9. Regulation FD Disclosure. Laboratory Corporation of America -Registered Trademark- Holdings (LabCorp -Registered Trademark-)(NYSE:LH) announced that Bradford T. Smith, executive vice president of public affairs, is scheduled to speak at the SG Cowen Global Health Care Conference in Paris, France on Thursday, November 29 at 10:20 a.m. (4:20 a.m. EST). The presentation will be webcast live, with a rebroadcast available for a period of 90 days, and may be heard online at At the conference, Mr. Smith will reiterate Company guidance for 2001 and 2002, as filed in an 8K on October 22. Mr. Smith will state, "For 2001, we expect revenue growth of 13.5 percent, EBITDA margins of approximately 21 percent of sales and EPS growth of approximately 55 percent compared to 2000. For 2002, we expect to increase overall revenues by approximately 12 percent compared to 2001 and we expect EPS growth, as calculated under existing accounting rules, of approximately 33 percent compared to 2001. In calculating earnings and EPS under the new accounting rules regarding goodwill, we expect the non-amortization of goodwill to have an impact of approximately $26 million in 2002, resulting in an increase to EPS of approximately $0.36." Each of the above forward-looking statements is subject to change based on various important factors, including without limitation, competitive actions in the marketplace and adverse actions of governmental and other third-party payors. Further information on potential factors that could affect LabCorp's financial results is included in the Company's Form 10-K for the year ended December 31, 2000 and subsequent SEC filings. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABORATORY CORPORATION OF AMERICA HOLDINGS ------------------------------------------ (Registrant) By:/s/ BRADFORD T. SMITH ---------------------------------- Bradford T. Smith Executive Vice President and Secretary Date: November 28, 2001

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period End:11/28/01
 List all Filings 
Filing Submission 0000920148-01-500042   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2020 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Oct. 31, 12:44:18.0am ET